KURA

Kura Oncology, Inc.

Healthcare · Biotechnology

$292.34 sample

-3.14 (-1.06%) 1D

Market cap

$1.24T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-04

Alerts

8

Price$292.34 +4.77% 3M daily closessample

300.38273.29

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: 10% owner
Sep 23INSInsider sell: Chief Financial Officer
Sep 14INSInsider sell: General Counsel
Sep 04SEC10-Q filed
Aug 31INSInsider sell: Chief Financial Officer
Aug 20SECDEF 14A filed
Aug 11SEC8-K filed: material event
Aug 03INSInsider sell: Director

Sign up to see the real KURA record →

Company facts

SEC EDGAR registration

Name: Kura Oncology, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +15sample, -100 to +100
Reporting currency: USD

Who is positioning in KURA

sample

Insiders: 15 insider transactions over 90 days, net selling, $208.3M
Congress: 3 members traded over 90 days
Institutions · 13F: 41 funds hold $25.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$35.4B +11.9% y/y

Q4 2024Q3 2026

Inventory$21.4B +15.4% y/y

Q4 2024Q3 2026

Accounts receivable$16.7B +20.9% y/y

Q4 2024Q3 2026

Total debt$41.8B +10.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.13T +5.8% 3M
Sample peer B: $1.16T -1.7% 3M
Sample peer C: $843.5B -2.1% 3M
Sample peer D: $819.1B -4.8% 3M
Sample peer E: $610.1B +12.6% 3M